CHG-2024-0229

Facility Change for Brextanib. Facility Change for Brextanib — major revision. Impacts 6 markets and 1 variations.

Change Number
CHG-2024-0229
Type
Facility Change
Product
Brextanib
Status
Pending
Owner
James O'Brien
Initiated
2023-12-12
Description

Facility Change for Brextanib — major revision

Impacted Markets (6)
EU — European UnionJP — JapanDE — GermanyTR — TurkeySA — Saudi ArabiaPL — Poland
Impacted Modules
4.2.12.3.P5.3.5
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved